Serial Number | 79230605 |
Word Mark | NORDIC NANOVECTOR |
Filing Date | Thursday, August 31, 2017 |
Status | 700 - REGISTERED |
Status Date | Tuesday, October 30, 2018 |
Registration Number | 5592658 |
Registration Date | Tuesday, October 30, 2018 |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, August 14, 2018 |
Description of Mark | The mark consists of the wording "NORDIC NANOVECTOR" in black to the right of a gray square containing a small, solid red circle and a stylized, white Y-shaped design comprised of four lines. |
Goods and Services | Pharmaceutical preparations and substances, namely, pharmaceutical preparations and substances for use in hematology, oncology and for the treatment of cancer; reagents for medical use; medical diagnostic chemicals and medical diagnostic reagents for medical use; antibody-based chemicals and reagents for medical use, namely, monoclonal antibodies, immuno-radiotherapies, antibody-radionuclide-conjugates; radiotherapies in the nature of chemotherapeutics that have a similar mechanism of action; diagnostic assay test kits for medical use consisting of medical diagnostic chemicals and reagents; biochemical preparations, namely, antibodies for medical diagnostic and therapeutic use |
Pseudo Mark | Y. NORDIC NANO VECTOR |
Indication of Colors claimed | The color(s) black, gray, white and red is/are claimed as a feature of the mark. |
Goods and Services | Medical services; medical services in the field of healing, in particular diagnostic services in the field of hematology, oncology and the treatment of cancer; medical services, namely, immuno-radiotherapies and radiotherapies in the field of hematology, oncology and the treatment of cancer |
Disclaimer with Predetermined Text | "NORDIC NANOVECTOR" |
Goods and Services | Medical and pharmaceutical research and development, namely, medical and pharmaceutical research and development in the field of hematology, oncology and the treatment of cancer; conducting clinical trials for others, namely, conducting clinical trials in the field of hematology, oncology and the treatment of cancer; providing medical research and scientific research information, namely, in the field of hematology, oncology and the treatment of cancer |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, April 27, 2018 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, April 27, 2018 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, April 27, 2018 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Nordic Nanovector ASA |
Party Type | 30 - Original Registrant |
Legal Entity Type | 84 - NOT AVAILABLE |
Address | NO |
Party Name | Nordic Nanovector ASA |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 84 - NOT AVAILABLE |
Address | NO |
Party Name | Nordic Nanovector ASA |
Party Type | 10 - Original Applicant |
Legal Entity Type | 84 - NOT AVAILABLE |
Address | NO |
Event Date | Event Description |
Monday, October 30, 2023 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
Monday, July 18, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Monday, July 18, 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
Monday, July 18, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Monday, July 18, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Saturday, March 16, 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Friday, March 15, 2019 | NEW REPRESENTATIVE AT IB RECEIVED |
Wednesday, February 13, 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
Wednesday, February 13, 2019 | FINAL DISPOSITION PROCESSED |
Wednesday, January 30, 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Thursday, January 24, 2019 | NEW REPRESENTATIVE AT IB RECEIVED |
Tuesday, October 30, 2018 | REGISTERED-PRINCIPAL REGISTER |
Friday, August 17, 2018 | NOTIFICATION PROCESSED BY IB |
Tuesday, August 14, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, August 14, 2018 | PUBLISHED FOR OPPOSITION |
Wednesday, August 1, 2018 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, August 1, 2018 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, July 25, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, July 3, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, July 2, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, July 2, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, July 2, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, May 25, 2018 | REFUSAL PROCESSED BY IB |
Monday, May 7, 2018 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Monday, May 7, 2018 | REFUSAL PROCESSED BY MPU |
Thursday, May 3, 2018 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Wednesday, May 2, 2018 | NON-FINAL ACTION WRITTEN |
Tuesday, May 1, 2018 | APPLICATION FILING RECEIPT MAILED |
Friday, April 27, 2018 | ASSIGNED TO EXAMINER |
Friday, April 27, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, April 26, 2018 | SN ASSIGNED FOR SECT 66A APPL FROM IB |